BVNRY:OTCMKTS
Bavarian Nordic A/S - ADR
US$11,09
arrow_downward
-0,05%(-0,0050) 1D
7 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BVNRY...
Open
US$10,96
High
US$11,09
Low
US$10,96
Mkt. cap
2,64 ຕື້
Avg. vol.
2,49 ພັນ
Volume
0,00
P/E ratio
11,85
52-wk high
US$13,00
52-wk low
US$8,67
EPS
US$0,94
Beta
1,45
Shares outstanding
237,82 ລ້ານ
No. of employees
2 ພັນ
Open
US$10,96
High
US$11,09
Low
US$10,96
Mkt. cap
2,64 ຕື້
Avg. vol.
2,49 ພັນ
Volume
0,00
P/E ratio
11,85
52-wk high
US$13,00
52-wk low
US$8,67
EPS
US$0,94
Beta
1,45
Shares outstanding
237,82 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Yahoo Finance
·
4 ຊົ່ວໂມງກ່ອນ
Bavarian Nordic lifts revenue, margin outlook on U.S. rabies vaccine demand
Investing.com
·
4 ຊົ່ວໂມງກ່ອນ
Why is Bavarian Nordic stock surging today?
TradingView
·
6 ຊົ່ວໂມງກ່ອນ
Bavarian Nordic Raises Revenue, EBITDA Margin Forecasts
GlobeNewswire
·
6 ຊົ່ວໂມງກ່ອນ
Bavarian Nordic Upgrades Full-Year 2026 Financial Guidance After Strong Travel Health Performance
Profile
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
About Bavarian Nordic A/S - ADR
CEOPaul Chaplin
Employees1,91 ພັນ
Founded1 ກ.ລ. 1992
Headquarters-
SectorBiotechnology
Websitebavarian-nordic.com